17/02/2025Published by Fondazione Gianni Bonadonna at 17/02/2025Categories Events UncategorizedTucatinib and trastuzumab in HER2-mutated metastatic breast cancer
10/02/2025Published by Fondazione Gianni Bonadonna at 10/02/2025Categories Events UncategorizedTalquetamab plus teclistamab in multiple myeloma
04/02/2025Published by Fondazione Gianni Bonadonna at 04/02/2025Categories Events UncategorizedThe fourth edition of the Fellowship named after Gianni Bonadonna awards three young researchers
27/01/2025Published by Fondazione Gianni Bonadonna at 27/01/2025Categories Events UncategorizedLenvatinib plus pembrolizumab added to transarterial embolization in hepatocellular carcinoma
20/01/2025Published by Fondazione Gianni Bonadonna at 20/01/2025Categories Events UncategorizedNeoadjuvant nivolumab plus ipilimumab in resectable lung cancer
13/01/2025Published by Fondazione Gianni Bonadonna at 13/01/2025Categories Events UncategorizedFianlimab and cemiplimab in patients with advanced tumors
23/12/2024Published by Fondazione Gianni Bonadonna at 23/12/2024Categories Events UncategorizedPaclitaxel and ramucirumab in advanced gastric or gastro-esophageal junction cancer
16/12/2024Published by Fondazione Gianni Bonadonna at 16/12/2024Categories Events UncategorizedEfficacy of neoadjuvant nivolumab/relatlimab in locally advanced colon cancer
09/12/2024Published by Fondazione Gianni Bonadonna at 09/12/2024Categories Events UncategorizedCamizestrant versus fulvestrant in postmenopausal advanced breast cancer
